Swiss Foy is a biotechnology startup founded in 2020, based in Switzerland. The company is dedicated to providing safe access to promising and proven longevity supplements, with a mission to enhance the quality of life and extend healthy lifespans. The slogan "We are passionate about providing the safest access to the most promising and proven longevity supplements available" reflects their commitment to consumer health. Swiss Foy acknowledges that they are not researchers or doctors, but they closely follow scientific advancements in health and longevity. They collaborate with scientific advisors to develop product lines based on the latest insights. The company emphasizes quality assurance, honest sourcing, and optimal distribution to offer high-grade products at competitive prices. Their adherence to Swiss quality standards and assurance that they only sell products they consume themselves highlights their commitment to integrity and consumer trust. Although based in Switzerland, the company operates from the UK due to the favorable regulatory environment for innovations in longevity and health. As of now, specific information about the startup's investors and investment deals is not available, indicating potential opportunities for investment or funding. With a focus on a burgeoning market and a commitment to scientific integrity, Swiss Foy presents itself as an intriguing opportunity for prospective investors in the biotechnology and health sectors.
There is no investment information
No recent news or press coverage available for Swiss Foy.